Galli1 recently provided an interesting review concerning precision medicine in allergy. He stated that, to his knowledge, no predictive tests have yet been shown to have clinical utility in predicting responses of individual patients to allergen immunotherapy (AIT). In addition, to underline the relevance of this issue, he cited Akdis and Akdis2 who noted that the general use of disease endotypes for allergies and asthma and correct selection of the responder patient population with defined biomarkers remain essential unmet needs in the clinical setting.
from A1 via xlomafota.13 on Inoreader http://ift.tt/2oVWfAr
via IFTTT
http://ift.tt/2p5yX8n
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου